<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Neomycin</id>
	<title>Neomycin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Neomycin"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Neomycin&amp;action=history"/>
	<updated>2026-05-11T03:03:05Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Neomycin&amp;diff=4968366&amp;oldid=prev</id>
		<title>Prab at 18:48, 16 September 2023</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Neomycin&amp;diff=4968366&amp;oldid=prev"/>
		<updated>2023-09-16T18:48:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Neomycin B C.svg|Neomycin B C structure|thumb]]&lt;br /&gt;
[[File:Neomycin ball-and-stick.png|Neomycin ball and stick|thumb]]&lt;br /&gt;
{{intro}} &lt;br /&gt;
[[neomycin]] is a broad spectrum aminoglycoside antibiotic whose current use is limited to oral and topical administration. &lt;br /&gt;
{{livtox}}&lt;br /&gt;
[[Neomycin]] has minimal oral absorption and its use has not been linked to instances of acute liver injury.&lt;br /&gt;
{{moa}}&lt;br /&gt;
[[Neomycin]] (nee&amp;quot; oh mye&amp;#039; sin) is an aminoglycoside with a broad spectrum of activity against both gram positive and gram negative organisms. Like other aminoglycosides, [[neomycin]] is thought to act by binding to [[bacteria]]l ribosomes and inhibiting protein synthesis. [[neomycin]] has activity against many aerobic gram negative and gram positive [[bacteria]], including the major [[E.Coli]] species resident in the colon as well as the enteropathogenic forms of [[E.Coli]] known to cause traveler’s diarrhea. Like other aminoglycosides, [[neomycin]] is poorly absorbed orally. The lack of absorption from the gastrointestinal tract is the basis of the main use of [[neomycin]], as an oral agent to suppress intestinal [[bacteria]]l flora. &lt;br /&gt;
{{use}}&lt;br /&gt;
Oral [[neomycin]] is indicated for treatment of infectious diarrhea, for suppression of intestinal [[bacteria]]l flora in patients undergoing colorectal surgery, and as a means of decreasing colonic [[bacteria]] and production of ammonia in hepatic encephalopathy. Topical [[neomycin]] is used for burns, wounds and ulcerations and as otic suspensions for external otitis. &lt;br /&gt;
{{dose}}&lt;br /&gt;
[[Neomycin]] is available in multiple generic forms including oral tablets of 500 mg. The typical adult dose of [[neomycin]] is 1 to 3 grams daily in four divided doses. &lt;br /&gt;
{{se}}&lt;br /&gt;
Long term therapy should be avoided because of the possibility of some systemic absorption and the high rate of oto- and nephrotoxicity associated with [[neomycin]] use. Other adverse events include nausea, diarrhea, and Clostridium difficile related colitis.&lt;br /&gt;
{{coststubd}}&lt;br /&gt;
{{Stomatological preparations}}&lt;br /&gt;
{{Antidiarrheals, intestinal anti-inflammatory and anti-infective agents}}&lt;br /&gt;
{{Antibiotics and chemotherapeutics for dermatological use}}&lt;br /&gt;
{{Protein synthesis inhibitor antibiotics}}&lt;br /&gt;
{{Throat preparations}}&lt;br /&gt;
{{Otologicals}}&lt;br /&gt;
[[Category:Aminoglycoside antibiotics]]&lt;br /&gt;
[[Category:Cell culture reagents]]&lt;br /&gt;
[[Category:DNA-binding substances]]&lt;br /&gt;
[[Category:Otologicals]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>